Curable film-forming compositions demonstrating increased wet-edge time

US10053596B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10053596-B2
Application numberUS-201615251216-A
CountryUS
Kind codeB2
Filing dateAug 30, 2016
Priority dateAug 30, 2016
Publication dateAug 21, 2018
Grant dateAug 21, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention is directed to a curable film-forming composition comprising: (a) a curing agent comprising reactive isocyanate functional groups; (b) a film-forming compound comprising functional groups reactive with the reactive isocyanate functional groups in (a); (c) a photo-latent catalyst; (d) a beta-diketone having a flash point higher than 60° C. (140° F.); and (e) a beta-diketone having a flash point lower than or equal to 60° C. (140° F.). The invention is further directed to methods of controlling the rate of cure and increasing the wet-edge time of a curable film-forming composition comprising an isocyanate functional curing agent, by adding to the curable film-forming composition a catalyst component comprising: (i) a photo-latent catalyst; (ii) a beta-diketone having a flash point higher than 60° C. (140° F.); and (iii) a beta-diketone having a flash point lower than or equal to 60° C. (140° F.).

First claim

Opening claim text (preview).

Therefore, we claim: 1. A curable film-forming composition comprising: (a) a curing agent comprising reactive isocyanate functional groups; (b) a film-forming compound comprising functional groups reactive with the reactive isocyanate functional groups in (a); (c) a photo-latent catalyst; (d) a beta-diketone having a flash point higher than 60° C. (140° F.) as measured using ASTM D56-16; and (e) a beta-diketone having a flash point lower than or equal to 60° C. (140° F.) as measured using ASTM D56-16. 2. The curable film-forming composition of claim 1 , wherein the beta-diketone (d) comprises an aliphatic, hindered beta-diketone. 3. The curable film-forming composition of claim 1 , wherein the beta-diketone (e) comprises an aliphatic beta-diketone. 4. The curable film-forming composition of claim 3 , wherein the beta-diketone (e) comprises 2,4-pentanedione. 5. The curable film-forming composition of claim 1 , wherein the curing agent (a) comprises a diisocyanate and/or a triisocyanate. 6. The curable film-forming composition of claim 1 , wherein the film-forming compound (b) comprises an acrylic polymer, a polyether polymer, and/or a polyester polymer. 7. The curable film-forming composition of claim 1 , wherein the photo-latent catalyst (c) comprises at least one organometallic compound of titanium, tin, aluminum, zirconium and/or bismuth. 8. The curable film-forming composition of claim 1 , wherein the photo-latent catalyst (c) is present in the curable film-forming composition in an amount of 0.01 to 2.0 percent by weight, based on the total weight of resin solids in the curable film-forming composition. 9. The curable film-forming composition of claim 1 , wherein the beta-diketone (d) is present in the curable film-forming composition in an amount of 0.01 to 8.0 percent by weight, based on the total weight of resin solids in the curable film-forming composition. 10. The curable film-forming composition of claim 1 , wherein the curable film-forming composition comprises a clear coat. 11. A method of controlling the rate of cure of a curable film-forming composition, comprising adding to the curable film-forming composition a catalyst component comprising: (i) a photo-latent catalyst; (ii) a beta-diketone having a flash point higher than 60° C. (140° F.) as measured using ASTM D56-16; and (iii) an aliphatic beta-diketone having a flash point lower than or equal to 60° C. (140° F.) as measured using ASTM D56-16, wherein the curable film-forming composition comprises: (a) a curing agent comprising reactive isocyanate functional groups; and (b) a film-forming compound comprising functional groups reactive with the reactive isocyanate functional groups in the curing agent (a). 12. The method of claim 11 , wherein the beta-diketone (ii) comprises an aliphatic, hindered beta-diketone. 13. The method of claim 11 , wherein the beta-diketone (iii) comprises 2,4-pentanedione. 14. The method of claim 11 , wherein the curing agent (a) comprises at least one of a diisocyanate and a triisocyanate. 15. The method of claim 11 , wherein the film-forming compound (b) comprises at least one of an acrylic polymer, a polyether polymer, and a polyester polymer. 16. The method of claim 11 , wherein the photo-latent catalyst (i) comprises at least one organometallic compound of titanium, tin, aluminum, zirconium or bismuth. 17. The method of claim 11 , further comprising after adding the catalyst component to the curable film-forming composition: applying the curable film-forming composition to a substrate to form a coated substrate; and exposing the coated substrate to conditions for a time sufficient to at least partially cure the curable film-forming composition. 18. The method of claim 17 , wherein the coated substrate is exposed to actinic radiation or to an elevated temperature for a time sufficient to at least partially cure the curable film-forming composition. 19. A method of increasing the wet-edge time of a curable film-forming composition, comprising adding to the curable film-forming composition a catalyst component comprising: (i) a photo-latent catalyst; (ii) a beta-diketone having a flash point higher than 60° C. (140° F.) as measured using ASTM D56-16; and (iii) an aliphatic beta-diketone having a flash point lower than or equal to 60° C. (140° F.) as measured using ASTM D56-16, wherein the curable film-forming composition comprises: (a) a curing agent comprising reactive isocyanate functional groups; and (b) a film-forming compound comprising functional groups reactive with the reactive isocyanate functional groups in the curing agent (a). 20. The method of claim 19 , wherein the beta-diketone (ii) comprises an aliphatic, hindered beta-diketone. 21. The method of claim 19 , wherein the beta-diketone (iii) comprises 2,4-pentanedione.

Assignees

Inventors

Classifications

  • containing secondary or tertiary amines or salts thereof · CPC title

  • Processes · CPC title

  • Polyurethanes · CPC title

  • the solvents being organic · CPC title

  • containing two or more components to be covered by at least two of the groups C08G18/166, C08G18/18 or C08G18/22 · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10053596B2 cover?
The present invention is directed to a curable film-forming composition comprising: (a) a curing agent comprising reactive isocyanate functional groups; (b) a film-forming compound comprising functional groups reactive with the reactive isocyanate functional groups in (a); (c) a photo-latent catalyst; (d) a beta-diketone having a flash point higher than 60° C. (140° F.); and (e) a beta-diketone…
Who is the assignee on this patent?
Prc Desoto Int Inc
What technology area does this patent fall under?
Primary CPC classification C08G18/0852. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 21 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).